These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14761161)

  • 1. Virtual generation of agents against Mycobacterium tuberculosis. A QSAR study.
    Besalú E; Ponec R; de Julián-Ortiz JV
    Mol Divers; 2003; 6(2):107-20. PubMed ID: 14761161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarity approach to QSAR. Application to antimycobacterial benzoxazines.
    Gallegos A; Carbó-Dorca R; Ponec R; Waisser K
    Int J Pharm; 2004 Jan; 269(1):51-60. PubMed ID: 14698576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syntheses and evaluation of benzodiazaborine compounds against M. tuberculosis H37Rv in vitro.
    Davis MC; Franzblau SG; Martin AR
    Bioorg Med Chem Lett; 1998 Apr; 8(7):843-6. PubMed ID: 9871552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the replacement of the oxo function with the thioxo group on the antimycobacterial activity of 3-aryl-6,8-dichloro-2H-1,3-benzoxazine-2,4(3H)-diones and 3-arylquinazoline-2,4(1H,3H)-diones.
    Waisser K; Gregor J; Dostál H; Kunes J; Kubicová L; Klimesová V; Kaustová J
    Farmaco; 2001 Oct; 56(10):803-7. PubMed ID: 11718275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
    Ventura C; Latino DA; Martins F
    Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of antitubercular nitroimidazoles. 2. Determinants of aerobic activity and quantitative structure-activity relationships.
    Kim P; Kang S; Boshoff HI; Jiricek J; Collins M; Singh R; Manjunatha UH; Niyomrattanakit P; Zhang L; Goodwin M; Dick T; Keller TH; Dowd CS; Barry CE
    J Med Chem; 2009 Mar; 52(5):1329-44. PubMed ID: 19209893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents.
    Patel SR; Gangwal R; Sangamwar AT; Jain R
    Eur J Med Chem; 2015 Mar; 93():511-22. PubMed ID: 25747550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycobacterial pyrroles: synthesis, anti-Mycobacterium tuberculosis activity and QSAR studies.
    Ragno R; Marshall GR; Di Santo R; Costi R; Massa S; Rompei R; Artico M
    Bioorg Med Chem; 2000 Jun; 8(6):1423-32. PubMed ID: 10896119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR).
    Singh S; Mandal PK; Singh N; Misra AK; Singh S; Chaturvedi V; Sinha S; Saxena AK
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2597-600. PubMed ID: 20304645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR based therapeutic management of M. tuberculosis.
    Ahamad S; Rahman S; Khan FI; Dwivedi N; Ali S; Kim J; Imtaiyaz Hassan M
    Arch Pharm Res; 2017 Jun; 40(6):676-694. PubMed ID: 28456911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antitubercular and anticancer activities of substituted furyl-quinazolin-3(4H)-ones.
    Raghavendra NM; Thampi P; Gurubasavarajaswamy PM; Sriram D
    Arch Pharm (Weinheim); 2007 Dec; 340(12):635-41. PubMed ID: 17994604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel camphane-based anti-tuberculosis agents with nanomolar activity.
    Stavrakov G; Valcheva V; Philipova I; Doytchinova I
    Eur J Med Chem; 2013; 70():372-9. PubMed ID: 24177364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines.
    Asquith CRM; Fleck N; Torrice CD; Crona DJ; Grundner C; Zuercher WJ
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2695-2699. PubMed ID: 31378571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitubercular constituents from the stem wood of Cinnamomum kotoense.
    Chen FC; Peng CF; Tsai IL; Chen IS
    J Nat Prod; 2005 Sep; 68(9):1318-23. PubMed ID: 16180806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents.
    Nayyar A; Malde A; Jain R; Coutinho E
    Bioorg Med Chem; 2006 Feb; 14(3):847-56. PubMed ID: 16214351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H37 RV MTB inhibitors.
    Khunt RC; Khedkar VM; Coutinho EC
    Chem Biol Drug Des; 2013 Dec; 82(6):669-84. PubMed ID: 23790070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.
    Maslov DA; Korotina AV; Shur KV; Vatlin AA; Bekker OB; Tolshchina SG; Ishmetova RI; Ignatenko NK; Rusinov GL; Charushin VN; Danilenko VN
    Eur J Med Chem; 2019 Sep; 178():39-47. PubMed ID: 31176094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents.
    Hevener KE; Ball DM; Buolamwini JK; Lee RE
    Bioorg Med Chem; 2008 Sep; 16(17):8042-53. PubMed ID: 18701298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents.
    Desai B; Sureja D; Naliapara Y; Shah A; Saxena AK
    Bioorg Med Chem; 2001 Aug; 9(8):1993-8. PubMed ID: 11504636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.